サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1155433

遺伝子毒性試験の世界市場規模、シェア、産業動向分析レポート：製品別、タイプ別、用途別（医薬品・バイオテクノロジー、食品産業、化粧品産業）、地域別展望と予測、2022年～2028年

Global Genetic Toxicology Testing Market Size, Share & Industry Trends Analysis Report By Product, By Type, By Application (Pharmaceutical & Biotechnology, Food Industry, Cosmetics Industry), By Regional Outlook and Forecast, 2022 - 2028
出版日: | 発行: KBV Research | ページ情報: 英文 199 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.70円
遺伝子毒性試験の世界市場規模、シェア、産業動向分析レポート：製品別、タイプ別、用途別（医薬品・バイオテクノロジー、食品産業、化粧品産業）、地域別展望と予測、2022年～2028年
出版日: 2022年10月31日
発行: KBV Research
ページ情報: 英文 199 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

遺伝子毒性試験の世界市場規模は、2028年までに24億米ドルに達し、予測期間中に13.2%のCAGRの市場成長率で上昇すると予測されています。

また、これらの研究は、試験管内創薬やテーラーメイド医薬品に集中しています。これらの用途に加えて、ヒト化動物モデルのニーズが高まっており、遺伝子毒性試験市場の主要な競合他社に多くのチャンスを与えることになるでしょう。遺伝子毒性試験は、化粧品、食品、医薬品、バイオテクノロジー産業でさまざまな用途に利用されています。

遺伝毒性情報の要件は、薬物研究・発見の増加やファーマコゲノミクスの利用拡大により増加することが予測されます。これは、染色体損傷や遺伝子変化を引き起こす可能性のある物質を評価することができるからです。また、遺伝子毒性試験分野の重要な成長要因は、世界の施設の整備と資金の確保です。

COVID-19影響度分析

ロックダウンによる製造業の操業停止や渡航制限の実施により、貨物の輸送に影響が出ており、COVID-19の急速な拡大により、医療機器や物資の不足が発生しています。COVID-19は、渡航制限と労働力不足による輸送関連の遅延を除いて、遺伝子毒性学に使用される原材料の入手に深刻な影響を及ぼしていないです。毒性研究は、ウイルスの変異を理解するために行われていました。また、COVID-19のウイルスに薬が効くかどうかを調べるために、遺伝毒性を利用する研究者も少なくなかっています。したがって、このパンデミックは、遺伝子毒性試験市場にプラスの影響を与えたといえます。

市場の成長要因

企業による医薬品研究開発への投資の増加

研究開発事業は、前臨床段階での物質の採用率を高めることで、フェーズIの治療薬候補が受け入れられる可能性を高めることを主目的としています。医薬品開発の初期段階においては、そのための研究開発活動が活発に行われています。そのため、遺伝毒性研究の必要性が高まっています。医薬品が高価な臨床段階に入る前に、医薬品の初期段階における研究開発費の増加は、in vivo毒性技術の利用を促進するとも予想されています。

動物を含むin vivo試験におけるヒト化手法の需要の増加

ヒト化したマウスを被験者として使用する生物医学研究用途がますます増えています。エール大学とジャクソン研究所（米国）の教授は、治療標的の特定とともに、ヒト黒色腫の生物学を理解するためのヒト化MISTRGモデルに関する高度な研究を行うために、2017年に3年間の助成金を授与されました。コネティカット・バイオサイエンス・イノベーションファンド（CBIF）は、2018年11月にジャクソン研究所とイェール大学（米国）に対して、70万米ドルの助成金を授与しました。この賞は、病気やがん治療に対する人の反応を正しく反映するヒト化マウスモデルを作成するための科学的共同研究を支援するものです。

市場の抑制要因

複雑なエンドポイント研究のための検証済みin vitroモデルの不足

ヒトのタンパク質や抗体が作られる新規医薬品の半分以上を占めることを考えると、自己免疫疾患や免疫活性化は医薬品開発にとって極めて重要なエンドポイントです。これらの医薬品は、まだ動物モデルでしか試験することができません。試験管内の遺伝子毒性試験技術を使用しても、二次感染後に体内で引き起こされる反応を評価することはできないです。また、短期的な免疫抑制と長期的な免疫抑制に対する身体の回復を評価することもできないです。

製品の展望

遺伝子毒性試験市場は、製品によって試薬・消耗品、アッセイ、サービスに分類されます。サービスセグメントは、2021年の遺伝子毒性試験市場で最大の収益シェアを調達しました。このセグメントの拡大は、この分野への投資を通じた契約研究機関（CRO）の戦略的野心の高まりによって促進されています。表皮・遺伝子毒性試験におけるサービス範囲の拡大も、サービス部門を加速させる要因の一つです。例えば、Gentronix社は、世界の需要増に対応するため、皮膚毒性分野のサービス範囲を拡大することを発表しています。

タイプ別展望

遺伝子毒性試験市場は、タイプ別にIn VitroとIn Vivoに二分されます。2021年の遺伝子毒性試験市場では、インビボ部門が大きな収益シェアを獲得しました。一般的に医学研究の不可欠な要素は、特に臨床試験におけるin vivo試験です。生体内（in vivo）で行われる研究は、物質の効果や病気の進行について有用な知識を提供します。臨床試験と動物実験がin vivo試験の2つの主要なカテゴリーです。

アプリケーションの展望

遺伝子毒性試験市場は、用途別に製薬・バイオテクノロジー、食品産業、化粧品産業、その他に区分されます。2021年の遺伝子毒性試験市場では、製薬・バイオテクノロジー分野が最大の収益シェアを示しています。上昇の原動力の1つは、医薬品の開発や研究における遺伝子毒性試験の広範な活用であると予測されます。遺伝子毒性試験は前臨床段階で行われます。また、バイオテクノロジーや製薬分野も速いペースで増加すると予測されています。あらゆる量の薬や物質に対して試験が必要であることを考えると。

地域別の展望

地域別では、遺伝子毒性試験市場は、北米、欧州、アジア太平洋およびLAMEAで分析されます。北米地域は、2021年に遺伝子毒性試験市場で最も高い収益シェアを示しました。同地域の優位性は、薬物開発の上昇と重要なパイプラインの支出に起因する可能性があります。さらに、この地域の重要なアクターの存在は、地元の製薬会社やバイオテクノロジー企業にとって、遺伝子毒性試験をより身近なものにしています。この業界の大きなシェアは、構造ベースの投薬設計の成長、生命科学研究への融資の増加、生物医薬品業界における高い研究開発費、北米における最先端技術の急速な取り込みに起因しています。

目次

第1章 市場の範囲と調査手法

  • 市場の定義
  • 目的
  • 市場規模
  • セグメンテーション
    • 遺伝子毒性試験の世界市場、製品別
    • 遺伝子毒性試験の世界市場、タイプ別
    • 遺伝子毒性試験の世界市場、用途別
    • 遺伝子毒性試験の世界市場、地域別
  • 調査手法

第2章 市場概要

  • イントロダクション
    • 概要説明
      • 市場の構成とシナリオ
  • 市場に影響を与える主な要因
    • 市場促進要因
    • 市場の抑制要因

第3章 遺伝子毒性試験市場で展開されている戦略

第4章 遺伝子毒性試験の世界市場：製品別

  • サービスの世界市場：地域別
  • 試薬・消耗品の地域別世界市場
  • アッセイの世界市場：地域別

第5章 遺伝子毒性試験の世界市場：タイプ別

  • In Vitroの世界市場：地域別
  • In Vivoの世界市場：地域別

第6章 遺伝子毒性試験の世界市場：アプリケーション別

  • 世界の製薬・バイオテクノロジー市場：地域別
  • 世界の食品産業市場：地域別
  • 化粧品業界の世界市場：地域別
  • 世界のその他地域別市場

第7章 遺伝子毒性試験の世界市場：地域別市場

  • 北米
    • 北米の遺伝子毒性試験の国別市場
      • 米国
      • カナダ
      • メキシコ
      • その他北米地域
  • 欧州
    • 欧州の遺伝子毒性試験市場：国別
      • ドイツ
      • 英国
      • フランス
      • ロシア
      • スペイン
      • イタリア
      • その他欧州
  • アジア太平洋地域
    • アジア太平洋地域の遺伝子毒性試験の国別市場
      • 中国
      • 日本
      • インド
      • 韓国
      • シンガポール
      • マレーシア
      • その他アジア太平洋地域
  • LAMEA
    • LAMEAの遺伝子毒性試験市場：国別
      • ブラジル
      • アルゼンチン
      • UAE
      • サウジアラビア
      • 南アフリカ共和国
      • ナイジェリア
      • LAMEAの残りの地域

第8章 企業プロファイル

  • Thermo Fisher Scientific, Inc.
  • Eurofins Scientific Group
  • Laboratory Corporation of America Holdings
  • Charles River Laboratories International, Inc.
  • Jubilant Pharmova Limited
  • Syngene International Limited
  • Gentronix Ltd.
  • Inotiv, Inc.
  • Creative Bioarray
  • MB Research Laboratories
図表

LIST OF TABLES

  • TABLE 1 Global Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 2 Global Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 3 Global Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 4 Global Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 5 Global Services Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Services Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Reagents & Consumables Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global Reagents & Consumables Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global Assays Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Assays Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 12 Global Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 13 Global In Vitro Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global In Vitro Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global In Vivo Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global In Vivo Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 18 Global Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 19 Global Pharmaceutical & Biotechnology Market by Region, 2018 - 2021, USD Million
  • TABLE 20 Global Pharmaceutical & Biotechnology Market by Region, 2022 - 2028, USD Million
  • TABLE 21 Global Food Industry Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Food Industry Market by Region, 2022 - 2028, USD Million
  • TABLE 23 Global Cosmetics Industry Market by Region, 2018 - 2021, USD Million
  • TABLE 24 Global Cosmetics Industry Market by Region, 2022 - 2028, USD Million
  • TABLE 25 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 26 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 27 Global Genetic Toxicology Testing Market by Region, 2018 - 2021, USD Million
  • TABLE 28 Global Genetic Toxicology Testing Market by Region, 2022 - 2028, USD Million
  • TABLE 29 North America Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 30 North America Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 31 North America Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 32 North America Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 33 North America Services Market by Country, 2018 - 2021, USD Million
  • TABLE 34 North America Services Market by Country, 2022 - 2028, USD Million
  • TABLE 35 North America Reagents & Consumables Market by Country, 2018 - 2021, USD Million
  • TABLE 36 North America Reagents & Consumables Market by Country, 2022 - 2028, USD Million
  • TABLE 37 North America Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 38 North America Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 39 North America Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 40 North America Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 41 North America In Vitro Market by Country, 2018 - 2021, USD Million
  • TABLE 42 North America In Vitro Market by Country, 2022 - 2028, USD Million
  • TABLE 43 North America In Vivo Market by Country, 2018 - 2021, USD Million
  • TABLE 44 North America In Vivo Market by Country, 2022 - 2028, USD Million
  • TABLE 45 North America Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 46 North America Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 47 North America Pharmaceutical & Biotechnology Market by Country, 2018 - 2021, USD Million
  • TABLE 48 North America Pharmaceutical & Biotechnology Market by Country, 2022 - 2028, USD Million
  • TABLE 49 North America Food Industry Market by Country, 2018 - 2021, USD Million
  • TABLE 50 North America Food Industry Market by Country, 2022 - 2028, USD Million
  • TABLE 51 North America Cosmetics Industry Market by Country, 2018 - 2021, USD Million
  • TABLE 52 North America Cosmetics Industry Market by Country, 2022 - 2028, USD Million
  • TABLE 53 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 54 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 55 North America Genetic Toxicology Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 56 North America Genetic Toxicology Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 57 US Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 58 US Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 59 US Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 60 US Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 61 US Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 62 US Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 63 US Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 64 Canada Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 65 Canada Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 66 Canada Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 67 Canada Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 68 Canada Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 69 Canada Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 70 Canada Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 71 Canada Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 72 Mexico Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 73 Mexico Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 74 Mexico Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 75 Mexico Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 76 Mexico Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 77 Mexico Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 78 Mexico Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 79 Mexico Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 80 Rest of North America Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 81 Rest of North America Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 82 Rest of North America Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 83 Rest of North America Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 84 Rest of North America Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 85 Rest of North America Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 86 Rest of North America Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 87 Rest of North America Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 88 Europe Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 89 Europe Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 90 Europe Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 91 Europe Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 92 Europe Services Market by Country, 2018 - 2021, USD Million
  • TABLE 93 Europe Services Market by Country, 2022 - 2028, USD Million
  • TABLE 94 Europe Reagents & Consumables Market by Country, 2018 - 2021, USD Million
  • TABLE 95 Europe Reagents & Consumables Market by Country, 2022 - 2028, USD Million
  • TABLE 96 Europe Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 97 Europe Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 98 Europe Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 99 Europe Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 100 Europe In Vitro Market by Country, 2018 - 2021, USD Million
  • TABLE 101 Europe In Vitro Market by Country, 2022 - 2028, USD Million
  • TABLE 102 Europe In Vivo Market by Country, 2018 - 2021, USD Million
  • TABLE 103 Europe In Vivo Market by Country, 2022 - 2028, USD Million
  • TABLE 104 Europe Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 105 Europe Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 106 Europe Pharmaceutical & Biotechnology Market by Country, 2018 - 2021, USD Million
  • TABLE 107 Europe Pharmaceutical & Biotechnology Market by Country, 2022 - 2028, USD Million
  • TABLE 108 Europe Food Industry Market by Country, 2018 - 2021, USD Million
  • TABLE 109 Europe Food Industry Market by Country, 2022 - 2028, USD Million
  • TABLE 110 Europe Cosmetics Industry Market by Country, 2018 - 2021, USD Million
  • TABLE 111 Europe Cosmetics Industry Market by Country, 2022 - 2028, USD Million
  • TABLE 112 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 113 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 114 Europe Genetic Toxicology Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 115 Europe Genetic Toxicology Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 116 Germany Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 117 Germany Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 118 Germany Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 119 Germany Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 120 Germany Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 121 Germany Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 122 Germany Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 123 Germany Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 124 UK Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 125 UK Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 126 UK Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 127 UK Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 128 UK Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 129 UK Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 130 UK Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 131 UK Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 132 France Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 133 France Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 134 France Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 135 France Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 136 France Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 137 France Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 138 France Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 139 France Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 140 Russia Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 141 Russia Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 142 Russia Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 143 Russia Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 144 Russia Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 145 Russia Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 146 Russia Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 147 Russia Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 148 Spain Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 149 Spain Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 150 Spain Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 151 Spain Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 152 Spain Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 153 Spain Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 154 Spain Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 155 Spain Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 156 Italy Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 157 Italy Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 158 Italy Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 159 Italy Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 160 Italy Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 161 Italy Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 162 Italy Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 163 Italy Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 164 Rest of Europe Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 165 Rest of Europe Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 166 Rest of Europe Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 167 Rest of Europe Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 168 Rest of Europe Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 169 Rest of Europe Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 170 Rest of Europe Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 171 Rest of Europe Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 172 Asia Pacific Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 173 Asia Pacific Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 174 Asia Pacific Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 175 Asia Pacific Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 176 Asia Pacific Services Market by Country, 2018 - 2021, USD Million
  • TABLE 177 Asia Pacific Services Market by Country, 2022 - 2028, USD Million
  • TABLE 178 Asia Pacific Reagents & Consumables Market by Country, 2018 - 2021, USD Million
  • TABLE 179 Asia Pacific Reagents & Consumables Market by Country, 2022 - 2028, USD Million
  • TABLE 180 Asia Pacific Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 181 Asia Pacific Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 182 Asia Pacific Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 183 Asia Pacific Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 184 Asia Pacific In Vitro Market by Country, 2018 - 2021, USD Million
  • TABLE 185 Asia Pacific In Vitro Market by Country, 2022 - 2028, USD Million
  • TABLE 186 Asia Pacific In Vivo Market by Country, 2018 - 2021, USD Million
  • TABLE 187 Asia Pacific In Vivo Market by Country, 2022 - 2028, USD Million
  • TABLE 188 Asia Pacific Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 189 Asia Pacific Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 190 Asia Pacific Pharmaceutical & Biotechnology Market by Country, 2018 - 2021, USD Million
  • TABLE 191 Asia Pacific Pharmaceutical & Biotechnology Market by Country, 2022 - 2028, USD Million
  • TABLE 192 Asia Pacific Food Industry Market by Country, 2018 - 2021, USD Million
  • TABLE 193 Asia Pacific Food Industry Market by Country, 2022 - 2028, USD Million
  • TABLE 194 Asia Pacific Cosmetics Industry Market by Country, 2018 - 2021, USD Million
  • TABLE 195 Asia Pacific Cosmetics Industry Market by Country, 2022 - 2028, USD Million
  • TABLE 196 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 197 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 198 Asia Pacific Genetic Toxicology Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 199 Asia Pacific Genetic Toxicology Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 200 China Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 201 China Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 202 China Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 203 China Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 204 China Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 205 China Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 206 China Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 207 China Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 208 Japan Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 209 Japan Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 210 Japan Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 211 Japan Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 212 Japan Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 213 Japan Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 214 Japan Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 215 Japan Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 216 India Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 217 India Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 218 India Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 219 India Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 220 India Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 221 India Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 222 India Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 223 India Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 224 South Korea Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 225 South Korea Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 226 South Korea Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 227 South Korea Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 228 South Korea Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 229 South Korea Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 230 South Korea Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 231 South Korea Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 232 Singapore Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 233 Singapore Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 234 Singapore Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 235 Singapore Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 236 Singapore Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 237 Singapore Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 238 Singapore Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 239 Singapore Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 240 Malaysia Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 241 Malaysia Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 242 Malaysia Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 243 Malaysia Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 244 Malaysia Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 245 Malaysia Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 246 Malaysia Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 247 Malaysia Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 248 Rest of Asia Pacific Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 249 Rest of Asia Pacific Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 250 Rest of Asia Pacific Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 251 Rest of Asia Pacific Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 252 Rest of Asia Pacific Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 253 Rest of Asia Pacific Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 254 Rest of Asia Pacific Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 255 Rest of Asia Pacific Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 256 LAMEA Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 257 LAMEA Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 258 LAMEA Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 259 LAMEA Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 260 LAMEA Services Market by Country, 2018 - 2021, USD Million
  • TABLE 261 LAMEA Services Market by Country, 2022 - 2028, USD Million
  • TABLE 262 LAMEA Reagents & Consumables Market by Country, 2018 - 2021, USD Million
  • TABLE 263 LAMEA Reagents & Consumables Market by Country, 2022 - 2028, USD Million
  • TABLE 264 LAMEA Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 265 LAMEA Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 266 LAMEA Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 267 LAMEA Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 268 LAMEA In Vitro Market by Country, 2018 - 2021, USD Million
  • TABLE 269 LAMEA In Vitro Market by Country, 2022 - 2028, USD Million
  • TABLE 270 LAMEA In Vivo Market by Country, 2018 - 2021, USD Million
  • TABLE 271 LAMEA In Vivo Market by Country, 2022 - 2028, USD Million
  • TABLE 272 LAMEA Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 273 LAMEA Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 274 LAMEA Pharmaceutical & Biotechnology Market by Country, 2018 - 2021, USD Million
  • TABLE 275 LAMEA Pharmaceutical & Biotechnology Market by Country, 2022 - 2028, USD Million
  • TABLE 276 LAMEA Food Industry Market by Country, 2018 - 2021, USD Million
  • TABLE 277 LAMEA Food Industry Market by Country, 2022 - 2028, USD Million
  • TABLE 278 LAMEA Cosmetics Industry Market by Country, 2018 - 2021, USD Million
  • TABLE 279 LAMEA Cosmetics Industry Market by Country, 2022 - 2028, USD Million
  • TABLE 280 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 281 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 282 LAMEA Genetic Toxicology Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 283 LAMEA Genetic Toxicology Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 284 Brazil Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 285 Brazil Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 286 Brazil Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 287 Brazil Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 288 Brazil Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 289 Brazil Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 290 Brazil Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 291 Brazil Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 292 Argentina Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 293 Argentina Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 294 Argentina Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 295 Argentina Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 296 Argentina Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 297 Argentina Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 298 Argentina Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 299 Argentina Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 300 UAE Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 301 UAE Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 302 UAE Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 303 UAE Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 304 UAE Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 305 UAE Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 306 UAE Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 307 UAE Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 308 Saudi Arabia Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 309 Saudi Arabia Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 310 Saudi Arabia Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 311 Saudi Arabia Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 312 Saudi Arabia Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 313 Saudi Arabia Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 314 Saudi Arabia Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 315 Saudi Arabia Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 316 South Africa Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 317 South Africa Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 318 South Africa Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 319 South Africa Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 320 South Africa Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 321 South Africa Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 322 South Africa Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 323 South Africa Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 324 Nigeria Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 325 Nigeria Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 326 Nigeria Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 327 Nigeria Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 328 Nigeria Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 329 Nigeria Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 330 Nigeria Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 331 Nigeria Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 332 Rest of LAMEA Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 333 Rest of LAMEA Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 334 Rest of LAMEA Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 335 Rest of LAMEA Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 336 Rest of LAMEA Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 337 Rest of LAMEA Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 338 Rest of LAMEA Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 339 Rest of LAMEA Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 340 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 341 Key Information - Eurofins Scientific Group
  • TABLE 342 Key Information - Laboratory Corporation of America holdings
  • TABLE 343 key information - Charles River Laboratories International, Inc.
  • TABLE 344 Key Information - Jubilant Pharmova Limited
  • TABLE 345 Key Information - Syngene International Limited
  • TABLE 346 Key Information - Gentronix Ltd.
  • TABLE 347 Key Information - INOTIV, INC.
  • TABLE 348 Key Information - Creative Bioarray
  • TABLE 349 Key Information - MB Research Laboratories

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Genetic Toxicology Testing Market Share by Product, 2021
  • FIG 3 Global Genetic Toxicology Testing Market Share by Product, 2028
  • FIG 4 Global Genetic Toxicology Testing Market by Product, 2018 - 2028, USD Million
  • FIG 5 Global Genetic Toxicology Testing Market Share by Type, 2021
  • FIG 6 Global Genetic Toxicology Testing Market Share by Type, 2028
  • FIG 7 Global Genetic Toxicology Testing Market by Type, 2018 - 2028, USD Million
  • FIG 8 Global Genetic Toxicology Testing Market Share by Application, 2021
  • FIG 9 Global Genetic Toxicology Testing Market Share by Application, 2028
  • FIG 10 Global Genetic Toxicology Testing Market by Application, 2018 - 2028, USD Million
  • FIG 11 Global Genetic Toxicology Testing Market Share by Region, 2021
  • FIG 12 Global Genetic Toxicology Testing Market Share by Region, 2028
  • FIG 13 Global Genetic Toxicology Testing Market by Region, 2018 - 2028, USD Million
  • FIG 14 Recent strategies and developments: Charles River Laboratories International, Inc.
目次

The Global Genetic Toxicology Testing Market size is expected to reach $2.4 billion by 2028, rising at a market growth of 13.2% CAGR during the forecast period.

The genetic toxicology testing research and observes the consequences of numerous physical, biological, and chemical substances on the heredity of live creatures. Genetic toxicology is the study of the harmful outcomes of DNA damage. These examinations are carried out either to detect chromosomal damage or gene mutation.

Agrochemicals, pharmaceutical impurities, chemicals utilized in the cosmetics industry, pharmaceutical medications, and industrial chemicals are all subjected to toxicological studies. Genetic toxicology is a crucial component of research and development (R&D), where novel medications are developed and designed through a variety of studies. These tests aid in the development of novel medications and vaccinations.

These studies also concentrate on in vitro drug discovery and tailored pharmaceuticals. In addition to these applications, there is a growing need for humanized animal models, which will present a plethora of chances for the major competitors in the genetic toxicology testing market. Testing for genetic toxicity has a variety of uses in the cosmetics, food, pharmaceutical, and biotech industries.

The requirement for genetic toxicology information is predicted to increase due to the increased medication research and discovery as well as the expanding usage of pharmacogenomics. This is because it can evaluate the substances that can cause chromosomal damage or genetic alterations. A significant growth factor in the genetic toxicity testing field is also the development of facilities and the availability of funding globally.

COVID - 19 Impact Analysis

Due to lockdowns that have halted manufacturing operations and enforced travel restrictions, affecting the transit of shipments, the rapid expansion of COVID-19 has resulted in a lack of medical equipment and supplies. COVID-19 has not severely affected the availability of raw materials used in genetic toxicology, with the exception of transportation-related delays brought on by travel restrictions and labor scarcity difficulties. Toxicology research was being conducted to comprehend the virus mutation. Similar to this, many researchers used genotoxic to evaluate how well medications worked on the COVID-19 virus. Therefore, it can be said that the pandemic had a positive impact on the genetic toxicology testing market.

Market Growth Factors

Rising investments in pharmaceutical R&D by companies

By raising the adoption of substances in the preclinical phases, R&D operations primarily aim to raise the overall likelihood of acceptance of Phase I therapeutic candidates. In the initial stages of medication development, intense R&D activities are carried out to accomplish this. The necessity for genetic toxicology research is consequently increased. Before a medicine enters the pricey clinical stages, higher R&D expenditures in the early phases of drug products are also anticipated to enhance the usage of in vivo toxicity techniques.

Increasing demand for humanized methods of in vivo testing including animals

More and more biomedical research applications use humanized mice as test subjects. Professors at Yale University and the Jackson Laboratory (US) were awarded a three-year grant in 2017 to perform advanced research on humanized MISTRG models for understanding the biology of human melanoma along with identifying therapeutic targets. The Connecticut Bioscience Innovation Fund (CBIF) awarded the Jackson Laboratory and Yale University (US) a grant in the amount of USD 700,000 in November 2018. This award supported scientific collaboration to create humanized mouse models that correctly reflect how people react to disease and cancer treatments.

Market Restraining Factors

Insufficient verified in vitro models for complex endpoint research

Given that human proteins and antibodies make over half of the novel medications created, autoimmune disease and immunological activation are crucial endpoints for drug development. These medicinal compounds can only yet be tested in animal models. The use of in vitro genetic toxicology testing techniques does not permit the assessment of the response induced within a body following secondary infection. These techniques can't assess how well a body recovers in response to short-term versus long-term immunosuppression.

Product Outlook

Based on product, the genetic toxicology testing market is classified into reagents & consumables, assays, and services. The service segment procured the largest revenue share in the genetic toxicology testing market in 2021. The segment expansion is being fuelled by Contract Research Organizations' (CROs') growing strategic ambitions through investment in this sector. The rising scope of services in the epidermis and genetic toxicological testing is another factor fuelling the service sector. For instance, in order to meet the growing demand around the world, Gentronix announced that the scope of its services in the field of cutaneous toxicity will be expanding.

Type Outlook

On the basis of type, the genetic toxicology testing market is bifurcated into In Vitro and In Vivo. The in vivo segment procured a significant revenue share in the genetic toxicology testing market in 2021. An essential component of medical research generally is in vivo testing, particularly in clinical trials. Studies conducted in living organisms (in vivo) offer useful knowledge about a substance's effects or the progression of a disease. Clinical trials and animal studies are the two main categories of in vivo testing.

Application Outlook

By application, the genetic toxicology testing market is segmented into pharmaceutical & biotechnology, food industry, cosmetics industry, and other. The pharmaceutical and biotechnology segment witnessed the maximum revenue share in the genetic toxicology testing market in 2021. It is projected that one of the driving forces behind the rise will be the extensive utilization of genotoxicity testing in medicine development and research. Testing for genetic toxicity is done at the preclinical stage. Additionally, it is predicted that the biotechnology and pharmaceutical sector will increase at a fast pace as well. Given that testing is necessary for all quantities of medications and substances.

Regional Outlook

Region-wise, the genetic toxicology testing market is analysed across North America, Europe, Asia Pacific and LAMEA. The North American region witnessed the highest revenue share in the genetic toxicology testing market in 2021. The dominance in the region can be due to rising medication development and significant pipeline spending. Additionally, the presence of important actors in the region makes genotoxicology testing more accessible for local pharmaceutical and biotech firms. The significant share of this industry is due to the growth of structure-based medication designs, rising financing for life sciences research, high R&D costs in the biopharmaceutical industry, and the burgeoning uptake of cutting-edge techniques in North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Charles River Laboratories International, Inc., Laboratory Corporation of America Holdings, Eurofins Scientific Group, Jubilant Pharmova Limited., Syngene International Limited, Gentronix Ltd., Inotiv Inc., Creative Bioarray and MB Research Laboratories.

Strategies deployed in Genetic Toxicology Testing Market

Feb-2022: Eurofins Clinical Testing Lux Sarl, a subsidiary of Eurofins Scientific acquired Genetic Testing Service, (Gentis), the market leader in specialized genetic analysis in Vietnam. With the acquisition, Eurofins focused on expanding its reach in Asia and complemented its worldwide network of clinical diagnostics laboratories working on technical and advanced genetic testing.

Jan-2022: Inotiv acquired Integrated Laboratory Systems, a portfolio company of Sier Capital Partners. Through the acquisition, Inotiv aimed to diversify the company's in vivo and in vitro toxicology services, comprising of prominent pathology and toxicology expertise. The acquisition increased the company's services into genomics, bioinformatics, and computational toxicology which further extended its market reach and created effective new cross-selling possibilities.

Sep-2021: Labcorp took over operating assets and intellectual property (IP) of the autoimmune business unit of Myriad Genetics, together with Vectra rheumatoid arthritis (RA) assay. The inclusion of Vectra testing abilities to Labcorp products' range presented the tremendous potential for the company to develop the test's availability and make Labcorp a single-source diagnostics solution for RA providers.

Aug-2021: Inotiv announced the acquisition of Gateway Pharmacology Laboratories, a preclinical contract research organization specializing in cardiovascular pharmacology studies. Following this acquisition, Inotiv augmented its array of in vivo abilities and integrated laboratory support assistance to include cardiovascular and renal pharmacology.

Jul-2021: Gentronix took over Big Blue transgenic mutation assay models by Bioreliance, the largest provider of outsourcing services focused on the rapidly growing biologics sector of the pharmaceutical industry. Through this acquisition, Gentronix aimed to double its revenues and augment its genetic toxicology capabilities in vitro skin and in vitro ocular toxicity testing.

Jun-2021: Charles River Laboratories acquired Vigene Biosciences, a premier, a gene therapy contract development and manufacturing organization. Through the acquisition, Charles River focused on augmenting its extensive cell and gene therapy range by utilizing the gene therapy expertise of Vigene Biosciences. The increased portfolio span incorporated each of the major CDMO platforms - cell therapy, viral vector, and plasmid DNA production.

Jan-2021: Charles River Laboratories partnered with Cypre, a biotechnology company that utilizes 3D hydrogel technology to advance the knowledge of the tumor microenvironment and predict therapeutic usefulness. This partnership helped the former company's clients with access to Falcon-X, Cypre's proprietary 3D tumor model platform. Moreover, the partnership broadened Charles River's 3D in vitro testing services to further optimize immuno-oncological methods for its clients.

Jan-2019: Charles River Laboratories formed an agreement with Toxys, a company that provides innovative in vitro toxicity screening solutions. Under the agreement, CRL focused on providing ToxTracker, a range of assays that enable rapid carcinogenicity toxicity hazard identification in novel and existing drugs, chemicals, and other substances in North America. The agreement equipped CRL's client base with the utilization of the ToxTracker assay that can assist in mitigating the risk of regulatory rejection by illustrating the exact mechanism of genotoxicity.

Scope of the Study

Market Segments covered in the Report:

By Product

  • Services
  • Reagents & Consumables
  • Assays

By Type

  • In Vitro
  • In Vivo

By Application

  • Pharmaceutical & Biotechnology
  • Food Industry
  • Cosmetics Industry
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Thermo Fisher Scientific, Inc.
  • Charles River Laboratories International, Inc.
  • Laboratory Corporation of America Holdings
  • Eurofins Scientific Group
  • Jubilant Pharmova Limited.
  • Syngene International Limited
  • Gentronix Ltd.
  • Inotiv Inc.
  • Creative Bioarray
  • MB Research Laboratories

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Genetic Toxicology Testing Market, by Product
    • 1.4.2 Global Genetic Toxicology Testing Market, by Type
    • 1.4.3 Global Genetic Toxicology Testing Market, by Application
    • 1.4.4 Global Genetic Toxicology Testing Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition & Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Strategies deployed in Genetic Toxicology Testing Market

Chapter 4. Global Genetic Toxicology Testing Market by Product

  • 4.1 Global Services Market by Region
  • 4.2 Global Reagents & Consumables Market by Region
  • 4.3 Global Assays Market by Region

Chapter 5. Global Genetic Toxicology Testing Market by Type

  • 5.1 Global In Vitro Market by Region
  • 5.2 Global In Vivo Market by Region

Chapter 6. Global Genetic Toxicology Testing Market by Application

  • 6.1 Global Pharmaceutical & Biotechnology Market by Region
  • 6.2 Global Food Industry Market by Region
  • 6.3 Global Cosmetics Industry Market by Region
  • 6.4 Global Others Market by Region

Chapter 7. Global Genetic Toxicology Testing Market by Region

  • 7.1 North America Genetic Toxicology Testing Market
    • 7.1.1 North America Genetic Toxicology Testing Market by Product
      • 7.1.1.1 North America Services Market by Country
      • 7.1.1.2 North America Reagents & Consumables Market by Country
      • 7.1.1.3 North America Assays Market by Country
    • 7.1.2 North America Genetic Toxicology Testing Market by Type
      • 7.1.2.1 North America In Vitro Market by Country
      • 7.1.2.2 North America In Vivo Market by Country
    • 7.1.3 North America Genetic Toxicology Testing Market by Application
      • 7.1.3.1 North America Pharmaceutical & Biotechnology Market by Country
      • 7.1.3.2 North America Food Industry Market by Country
      • 7.1.3.3 North America Cosmetics Industry Market by Country
      • 7.1.3.4 North America Others Market by Country
    • 7.1.4 North America Genetic Toxicology Testing Market by Country
      • 7.1.4.1 US Genetic Toxicology Testing Market
        • 7.1.4.1.1 US Genetic Toxicology Testing Market by Product
        • 7.1.4.1.2 US Genetic Toxicology Testing Market by Type
        • 7.1.4.1.3 US Genetic Toxicology Testing Market by Application
      • 7.1.4.2 Canada Genetic Toxicology Testing Market
        • 7.1.4.2.1 Canada Genetic Toxicology Testing Market by Product
        • 7.1.4.2.2 Canada Genetic Toxicology Testing Market by Type
        • 7.1.4.2.3 Canada Genetic Toxicology Testing Market by Application
      • 7.1.4.3 Mexico Genetic Toxicology Testing Market
        • 7.1.4.3.1 Mexico Genetic Toxicology Testing Market by Product
        • 7.1.4.3.2 Mexico Genetic Toxicology Testing Market by Type
        • 7.1.4.3.3 Mexico Genetic Toxicology Testing Market by Application
      • 7.1.4.4 Rest of North America Genetic Toxicology Testing Market
        • 7.1.4.4.1 Rest of North America Genetic Toxicology Testing Market by Product
        • 7.1.4.4.2 Rest of North America Genetic Toxicology Testing Market by Type
        • 7.1.4.4.3 Rest of North America Genetic Toxicology Testing Market by Application
  • 7.2 Europe Genetic Toxicology Testing Market
    • 7.2.1 Europe Genetic Toxicology Testing Market by Product
      • 7.2.1.1 Europe Services Market by Country
      • 7.2.1.2 Europe Reagents & Consumables Market by Country
      • 7.2.1.3 Europe Assays Market by Country
    • 7.2.2 Europe Genetic Toxicology Testing Market by Type
      • 7.2.2.1 Europe In Vitro Market by Country
      • 7.2.2.2 Europe In Vivo Market by Country
    • 7.2.3 Europe Genetic Toxicology Testing Market by Application
      • 7.2.3.1 Europe Pharmaceutical & Biotechnology Market by Country
      • 7.2.3.2 Europe Food Industry Market by Country
      • 7.2.3.3 Europe Cosmetics Industry Market by Country
      • 7.2.3.4 Europe Others Market by Country
    • 7.2.4 Europe Genetic Toxicology Testing Market by Country
      • 7.2.4.1 Germany Genetic Toxicology Testing Market
        • 7.2.4.1.1 Germany Genetic Toxicology Testing Market by Product
        • 7.2.4.1.2 Germany Genetic Toxicology Testing Market by Type
        • 7.2.4.1.3 Germany Genetic Toxicology Testing Market by Application
      • 7.2.4.2 UK Genetic Toxicology Testing Market
        • 7.2.4.2.1 UK Genetic Toxicology Testing Market by Product
        • 7.2.4.2.2 UK Genetic Toxicology Testing Market by Type
        • 7.2.4.2.3 UK Genetic Toxicology Testing Market by Application
      • 7.2.4.3 France Genetic Toxicology Testing Market
        • 7.2.4.3.1 France Genetic Toxicology Testing Market by Product
        • 7.2.4.3.2 France Genetic Toxicology Testing Market by Type
        • 7.2.4.3.3 France Genetic Toxicology Testing Market by Application
      • 7.2.4.4 Russia Genetic Toxicology Testing Market
        • 7.2.4.4.1 Russia Genetic Toxicology Testing Market by Product
        • 7.2.4.4.2 Russia Genetic Toxicology Testing Market by Type
        • 7.2.4.4.3 Russia Genetic Toxicology Testing Market by Application
      • 7.2.4.5 Spain Genetic Toxicology Testing Market
        • 7.2.4.5.1 Spain Genetic Toxicology Testing Market by Product
        • 7.2.4.5.2 Spain Genetic Toxicology Testing Market by Type
        • 7.2.4.5.3 Spain Genetic Toxicology Testing Market by Application
      • 7.2.4.6 Italy Genetic Toxicology Testing Market
        • 7.2.4.6.1 Italy Genetic Toxicology Testing Market by Product
        • 7.2.4.6.2 Italy Genetic Toxicology Testing Market by Type
        • 7.2.4.6.3 Italy Genetic Toxicology Testing Market by Application
      • 7.2.4.7 Rest of Europe Genetic Toxicology Testing Market
        • 7.2.4.7.1 Rest of Europe Genetic Toxicology Testing Market by Product
        • 7.2.4.7.2 Rest of Europe Genetic Toxicology Testing Market by Type
        • 7.2.4.7.3 Rest of Europe Genetic Toxicology Testing Market by Application
  • 7.3 Asia Pacific Genetic Toxicology Testing Market
    • 7.3.1 Asia Pacific Genetic Toxicology Testing Market by Product
      • 7.3.1.1 Asia Pacific Services Market by Country
      • 7.3.1.2 Asia Pacific Reagents & Consumables Market by Country
      • 7.3.1.3 Asia Pacific Assays Market by Country
    • 7.3.2 Asia Pacific Genetic Toxicology Testing Market by Type
      • 7.3.2.1 Asia Pacific In Vitro Market by Country
      • 7.3.2.2 Asia Pacific In Vivo Market by Country
    • 7.3.3 Asia Pacific Genetic Toxicology Testing Market by Application
      • 7.3.3.1 Asia Pacific Pharmaceutical & Biotechnology Market by Country
      • 7.3.3.2 Asia Pacific Food Industry Market by Country
      • 7.3.3.3 Asia Pacific Cosmetics Industry Market by Country
      • 7.3.3.4 Asia Pacific Others Market by Country
    • 7.3.4 Asia Pacific Genetic Toxicology Testing Market by Country
      • 7.3.4.1 China Genetic Toxicology Testing Market
        • 7.3.4.1.1 China Genetic Toxicology Testing Market by Product
        • 7.3.4.1.2 China Genetic Toxicology Testing Market by Type
        • 7.3.4.1.3 China Genetic Toxicology Testing Market by Application
      • 7.3.4.2 Japan Genetic Toxicology Testing Market
        • 7.3.4.2.1 Japan Genetic Toxicology Testing Market by Product
        • 7.3.4.2.2 Japan Genetic Toxicology Testing Market by Type
        • 7.3.4.2.3 Japan Genetic Toxicology Testing Market by Application
      • 7.3.4.3 India Genetic Toxicology Testing Market
        • 7.3.4.3.1 India Genetic Toxicology Testing Market by Product
        • 7.3.4.3.2 India Genetic Toxicology Testing Market by Type
        • 7.3.4.3.3 India Genetic Toxicology Testing Market by Application
      • 7.3.4.4 South Korea Genetic Toxicology Testing Market
        • 7.3.4.4.1 South Korea Genetic Toxicology Testing Market by Product
        • 7.3.4.4.2 South Korea Genetic Toxicology Testing Market by Type
        • 7.3.4.4.3 South Korea Genetic Toxicology Testing Market by Application
      • 7.3.4.5 Singapore Genetic Toxicology Testing Market
        • 7.3.4.5.1 Singapore Genetic Toxicology Testing Market by Product
        • 7.3.4.5.2 Singapore Genetic Toxicology Testing Market by Type
        • 7.3.4.5.3 Singapore Genetic Toxicology Testing Market by Application
      • 7.3.4.6 Malaysia Genetic Toxicology Testing Market
        • 7.3.4.6.1 Malaysia Genetic Toxicology Testing Market by Product
        • 7.3.4.6.2 Malaysia Genetic Toxicology Testing Market by Type
        • 7.3.4.6.3 Malaysia Genetic Toxicology Testing Market by Application
      • 7.3.4.7 Rest of Asia Pacific Genetic Toxicology Testing Market
        • 7.3.4.7.1 Rest of Asia Pacific Genetic Toxicology Testing Market by Product
        • 7.3.4.7.2 Rest of Asia Pacific Genetic Toxicology Testing Market by Type
        • 7.3.4.7.3 Rest of Asia Pacific Genetic Toxicology Testing Market by Application
  • 7.4 LAMEA Genetic Toxicology Testing Market
    • 7.4.1 LAMEA Genetic Toxicology Testing Market by Product
      • 7.4.1.1 LAMEA Services Market by Country
      • 7.4.1.2 LAMEA Reagents & Consumables Market by Country
      • 7.4.1.3 LAMEA Assays Market by Country
    • 7.4.2 LAMEA Genetic Toxicology Testing Market by Type
      • 7.4.2.1 LAMEA In Vitro Market by Country
      • 7.4.2.2 LAMEA In Vivo Market by Country
    • 7.4.3 LAMEA Genetic Toxicology Testing Market by Application
      • 7.4.3.1 LAMEA Pharmaceutical & Biotechnology Market by Country
      • 7.4.3.2 LAMEA Food Industry Market by Country
      • 7.4.3.3 LAMEA Cosmetics Industry Market by Country
      • 7.4.3.4 LAMEA Others Market by Country
    • 7.4.4 LAMEA Genetic Toxicology Testing Market by Country
      • 7.4.4.1 Brazil Genetic Toxicology Testing Market
        • 7.4.4.1.1 Brazil Genetic Toxicology Testing Market by Product
        • 7.4.4.1.2 Brazil Genetic Toxicology Testing Market by Type
        • 7.4.4.1.3 Brazil Genetic Toxicology Testing Market by Application
      • 7.4.4.2 Argentina Genetic Toxicology Testing Market
        • 7.4.4.2.1 Argentina Genetic Toxicology Testing Market by Product
        • 7.4.4.2.2 Argentina Genetic Toxicology Testing Market by Type
        • 7.4.4.2.3 Argentina Genetic Toxicology Testing Market by Application
      • 7.4.4.3 UAE Genetic Toxicology Testing Market
        • 7.4.4.3.1 UAE Genetic Toxicology Testing Market by Product
        • 7.4.4.3.2 UAE Genetic Toxicology Testing Market by Type
        • 7.4.4.3.3 UAE Genetic Toxicology Testing Market by Application
      • 7.4.4.4 Saudi Arabia Genetic Toxicology Testing Market
        • 7.4.4.4.1 Saudi Arabia Genetic Toxicology Testing Market by Product
        • 7.4.4.4.2 Saudi Arabia Genetic Toxicology Testing Market by Type
        • 7.4.4.4.3 Saudi Arabia Genetic Toxicology Testing Market by Application
      • 7.4.4.5 South Africa Genetic Toxicology Testing Market
        • 7.4.4.5.1 South Africa Genetic Toxicology Testing Market by Product
        • 7.4.4.5.2 South Africa Genetic Toxicology Testing Market by Type
        • 7.4.4.5.3 South Africa Genetic Toxicology Testing Market by Application
      • 7.4.4.6 Nigeria Genetic Toxicology Testing Market
        • 7.4.4.6.1 Nigeria Genetic Toxicology Testing Market by Product
        • 7.4.4.6.2 Nigeria Genetic Toxicology Testing Market by Type
        • 7.4.4.6.3 Nigeria Genetic Toxicology Testing Market by Application
      • 7.4.4.7 Rest of LAMEA Genetic Toxicology Testing Market
        • 7.4.4.7.1 Rest of LAMEA Genetic Toxicology Testing Market by Product
        • 7.4.4.7.2 Rest of LAMEA Genetic Toxicology Testing Market by Type
        • 7.4.4.7.3 Rest of LAMEA Genetic Toxicology Testing Market by Application

Chapter 8. Company Profiles

  • 8.1 Thermo Fisher Scientific, Inc.
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expense
  • 8.2 Eurofins Scientific Group
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Regional Analysis
    • 8.2.4 Recent strategies and developments:
      • 8.2.4.1 Acquisition and Mergers:
  • 8.3 Laboratory Corporation of America Holdings
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental Analysis
    • 8.3.4 Recent strategies and developments:
      • 8.3.4.1 Acquisition and Mergers:
  • 8.4 Charles River Laboratories International, Inc.
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Recent strategies and developments:
      • 8.4.4.1 Partnerships, Collaborations, and Agreements:
      • 8.4.4.2 Acquisition and Mergers:
  • 8.5 Jubilant Pharmova Limited
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Segmental and Regional Analysis
    • 8.5.4 Research & Development Expenses
  • 8.6 Syngene International Limited
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Regional Analysis
  • 8.7 Gentronix Ltd.
    • 8.7.1 Company Overview
    • 8.7.2 Recent strategies and developments:
      • 8.7.2.1 Acquisition and Mergers:
  • 8.8 Inotiv, Inc.
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Segmental and Regional Analysis
    • 8.8.4 Research & Development Expenses
    • 8.8.5 Recent strategies and developments:
      • 8.8.5.1 Acquisition and Mergers:
  • 8.9 Creative Bioarray
    • 8.9.1 Company Overview
  • 8.10. MB Research Laboratories
    • 8.10.1 Company Overview